Loading provider…
Loading provider…
Rheumatology Physician in Dayton, OH
NPI: 1255390233Primary Practice Location
MIAMI VALLEY HOSPITAL
1 Wyoming St, Dayton, OH
Primary Employer
Mvhe Inc
premierhealth.com
HQ Phone
Get DO Sanford's Phone Numberphone_androidMobile
Get DO Sanford's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 182 | 410 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 117 | 177 |
| 3 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 105 | 263 |
| 4 | J0897Injection, denosumab, 1 mg | 89 | 8,820 |
| 5 | J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 45 | 450 |
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Rituximab, DRUG: Belimumab, DRUG: Rituximab-placebo, DRUG: Standard therapy (Including Immunosuppressants), DRUG: Standard therapy (Excluding Immunosuppressants), DRUG: Steroid Taper
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: Placebo, BIOLOGICAL: GSK3196165 (Otilimab), DRUG: Tofacitinib 5 mg
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: BIOLOGICAL: Otilimab (GSK3196165), DRUG: csDMARD(s)